Fecal transplantation indications in ulcerative colitis. preliminary study

Clujul Medical

Volumn 89, Issue 2, 2016, Pages 224-228

  Laszlo, Mihaela ^a   Ciobanu, Lidia ^a,b   Andreica, Vasile ^a,b   Pascu, Oliviu ^a,b  

^a REGIONAL INSTITUTE OF GASTROENTEROLOGY AND HEPATOLOGY   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Biological therapy; Clostridium difficile; Fecal transplantation; Ulcerative colitis

Indexed keywords

EID: 84964974145     PISSN: 12222119     EISSN: 20668872     Source Type: Journal    
DOI: 10.15386/cjmed-613     Document Type: Article

References (15)

1. Robles-Alonso V, Guarner F. Gut microbes. World Gastroenterology News. 2014;19:6-11.
2. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013;6(4):295-308.
3. Borody TJ, Paramsothy S, Agrawal G. Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions. Curr Gastroenterol Rep. 2013;15(8):337.
4. Guarner F. What is the role of the enteric commensal flora in IBD? Inflamm Bowel Dis. 2008;14 Suppl 2: S83-S84.
5. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eechkaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63(8):1275-1283.
6. Angelberger S, Reinisch W. Makristathis A, Lichtenberger C, Dejaco C, Papay P, et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013;108(10):1620-1630.
7. Zhang FM, Wang HC, Wang M, Cui BT, Fan ZN, Ji GZ. Fecal microbiota transplantation for severe enterocolonic fistulizing Crohn's disease. World J Gastroenterol. 2013;19(41):7213-7216.
8. Kruis W, Schutz E, Fric P, Fixa B, Judmaier G, Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther. 1997;11(5):853-858
9. Vindigni SM, Broussard EK, Surawicz CM. Alteration of the intestinal microbiome: fecal microbiota transplant and probiotics for Clostridium difficile and beyond. Expert Rev Gastroenterol Hepatol. 2013;7(7):615-628.
10. Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015;30(1):51-58.
11. Brandt LJ. American Journal of Gastroenterology Lecture: Intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am J Gastroenterol. 2013;108(2):177-185.
12. Khanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin Proc. 2014; 89(1):107-114.
13. Harrison P. Microbiome Opens Door to Brave New World of Therapeutics 2013. Available from: http:/www.medscape.com.
14. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107(11):1755.
15. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307(5717):1915-1920.